Deutsche Bank AG Cuts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Deutsche Bank AG trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 5.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,341,917 shares of the financial services provider's stock after selling 83,579 shares during the period. Deutsche Bank AG owned about 0.37% of CME Group worth $311,633,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CME. Norges Bank purchased a new position in CME Group in the fourth quarter worth about $1,107,389,000. Price T Rowe Associates Inc. MD boosted its position in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Raymond James Financial Inc. purchased a new position in CME Group in the fourth quarter worth about $871,063,000. Capital Wealth Planning LLC boosted its position in CME Group by 69.2% in the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock worth $565,671,000 after purchasing an additional 996,498 shares during the last quarter. Finally, Egerton Capital UK LLP purchased a new position in CME Group in the fourth quarter worth about $223,967,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Price Performance

Shares of NASDAQ:CME traded up $2.36 during midday trading on Friday, reaching $284.35. 953,386 shares of the company were exchanged, compared to its average volume of 2,155,183. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The business's fifty day moving average is $264.47 and its two-hundred day moving average is $245.78. CME Group Inc. has a one year low of $190.70 and a one year high of $286.48. The stock has a market cap of $102.47 billion, a PE ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.50 earnings per share. As a group, analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. CME Group's dividend payout ratio (DPR) is 50.30%.

Insider Transactions at CME Group

In other news, Director Dennis Suskind sold 1,000 shares of the firm's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total value of $271,280.00. Following the completion of the sale, the director now owns 2,915 shares in the company, valued at approximately $790,781.20. This trade represents a 25.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the completion of the sale, the insider now owns 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock valued at $8,975,813 in the last ninety days. Corporate insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CME shares. Keefe, Bruyette & Woods increased their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Bank of America raised their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research note on Wednesday, April 2nd. Barclays raised their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 23rd. Finally, Raymond James upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price on the stock in a research note on Monday, March 10th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, CME Group has an average rating of "Hold" and an average target price of $256.80.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.